Turkish Validation of the HOOS-12
ConditionHip Osteoarthritis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHacettepe University
About this trial
The Hip Disability and Osteoarthritis Outcome Score-12 (HOOS-12) is a short patient-reported outcome measure developed to assess pain, function, and hip-related quality of life in individuals with hip osteoarthritis. Although widely used internationally, a validated Turkish version is currently unavailable. This study aims to translate and culturally adapt the HOOS-12 into Turkish and evaluate its psychometric properties, including internal consistency, test-retest reliability, construct validity, structural validity, responsiveness, and measurement error, in Turkish-speaking patients with hip osteoarthritis.
Eligibility criteria
Qualifiers
Age 18 years or older.
Native Turkish speaker or able to read and understand Turkish fluently.
Diagnosed with primary hip osteoarthritis based on clinical and radiographic evaluation.
Scheduled to undergo primary total hip arthroplasty.
Disqualifiers
Previous total hip arthroplasty on the affected side.
Scheduled for revision hip arthroplasty.
Hip arthroplasty indicated for conditions other than primary hip osteoarthritis, including hip fracture, inflammatory arthritis, avascular necrosis, congenital hip disorders, or malignancy.
History of major lower-extremity surgery within the previous six months.
Trial design
Treatments tested in this trial
- Patient-Reported Outcome Assessment
Treatment groups
150 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov